4.4 Article

Prospective diagnosis of MT-ATP6-related mitochondrial disease by newborn screening

期刊

MOLECULAR GENETICS AND METABOLISM
卷 134, 期 1-2, 页码 37-42

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymgme.2021.06.007

关键词

Leigh syndrome; Citrulline; Acylcarnitine; Newborn screening; Mitochondrial disease; Amino acids

资金

  1. Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health [R03-DK125662]
  2. National Institute of Diabetes and Digestive and Kidney Diseases

向作者/读者索取更多资源

Elevated citrulline and C5-OH levels in newborn screening may indicate pathogenic variants in MT-ATP6, which can lead to Leigh syndrome. Early diagnosis and treatment with supplemental citrulline can prevent neurological sequelae. Asymptomatic or paucisymptomatic carriers of MT-ATP6 pathogenic variants in affected families have expanded the clinical spectrum.
Elevated citrulline and C5-OH levels are reported as part of the newborn screening of core and secondary disor-ders on the Recommended Uniform Screening Panel (RUSP). Additionally, some state laboratory newborn screening programs report low citrulline levels, which may be observed in proximal urea cycle disorders. We re-port six patients who were found on newborn screening to have low citrulline and/or elevated C5-OH levels in whom confirmatory testing showed the combination of these two abnormal analytes. Mitochondrial sequencing revealed known pathogenic variants in MT-ATP6 at high heteroplasmy levels in all cases. MT-ATP6 at these heteroplasmy levels is associated with Leigh syndrome, a progressive neurodegenerative disease. Patients were treated with supplemental citrulline and, in some cases, mitochondrial cofactor therapy. These six patients have not experienced metabolic crises or developmental regression, and early diagnosis and management may help prevent the neurological sequelae of Leigh syndrome. The affected mothers and siblings are asymptomatic or paucisymptomatic (e.g. intellectual disability, depression, migraines, obsessive-compulsive disorder, and poor balance) despite high heteroplasmy or apparent homoplasmy of the familial variant, thus expanding the clinical spectrum seen in pathogenic variants of MT-ATP6. Confirmatory plasma amino acid analysis and acylcarnitine profiling should be ordered in a patient with either low citrulline and/or elevated C5-OH, as this combination ap-pears specific for pathogenic variants in MT-ATP6. (c) 2021 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据